Abstract
Two human cell lines (UACC-812 and 893), both containing significant amplification of the HER-2/neu gene, were established from biopsy specimens of breast carcinomas. One patient had Stage II breast carcinoma; the other had metastatic disease. Characterisation of these lines has revealed that both are highly aneuploid containing multiple clonal chromosome alterations, have doubling times near 100 h, and are oestrogen and progesterone receptor negative. Electron microscopy demonstrates that both lines contain numerous microvilli, cytoplasmic filaments, multivesicular bodies, and desmosomes. Immunoblot analysis for P-glycoprotein using the monoclonal antibody C219 was negative for both patient cell lines. These relatively rare cell lines may represent a useful model to investigate human breast carcinomas.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meltzer, P., Leibovitz, A., Dalton, W. et al. Establishment of two new cell lines derived from human breast carcinomas with HER-2/neu amplification. Br J Cancer 63, 727–735 (1991). https://doi.org/10.1038/bjc.1991.164
Issue Date:
DOI: https://doi.org/10.1038/bjc.1991.164
This article is cited by
-
Establishment and characterization of three stable Basal/HER2-positive breast cancer cell lines derived from Chinese breast carcinoma with identical missense mutations in the DNA-binding domain of TP53
Cancer Cell International (2018)
-
Establishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: mutation analysis
Cancer Cell International (2014)
-
Establishment and characterization of two human breast carcinoma cell lines by spontaneous immortalization: Discordance between Estrogen, Progesterone and HER2/neu receptors of breast carcinoma tissues with derived cell lines
Cancer Cell International (2012)
-
Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines
Breast Cancer Research and Treatment (2009)
-
Clonogenic growth of human breast cancer cells co-cultured in direct contact with serum-activated fibroblasts
Breast Cancer Research (2005)